Navigation Links
Lupin Announces Launch of Generic KEPPRA XR® Tablets
Date:9/14/2011

BALTIMORE, Sept. 14, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of UCB's KEPPRA XR tablets.  Commercial shipment of the product has commenced.

Lupin's levetiracetam 500 mg and 750 mg extended-release tablets are the AB-rated generic equivalent of KEPPRA XR, an antiepileptic drug indicated for adjunctive therapy in the treatment of partial onset seizures in patients >/= 16 years of age with epilepsy.  KEPPRA XR tablets had annual sales of approximately $161 million for the twelve months ended June 2011 based on IMS Health sales data.

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs.  The Company today has significant market share in Cardiovasculars, Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs in addition holding global leadership positions in the Anti-TB and Cephalosporins space.

Today, Lupin is the 5th largest and fastest growing generics player in the US (by prescriptions), the only Asian company to achieve that distinction.  The company is also the fastest growing top 10 pharmaceutical player in India, Japan and South Africa. (IMS Health)

For the financial year ended March 2011, Lupin's Consolidated Revenues and Profit after Tax were Rs. 57,068 million (USD 1.28 Billion) and Rs. 8,626 million (USD 193 million) respectively.  Please visit http://www.lupinworld.com for more information about Lupin Ltd.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited.  Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines and branded formulations trusted by healthcare professionals and patients across geographies.  For more information, visit http://www.lupinpharmaceuticals.com.

Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Many of these risks, uncertainties and other factors include failure of clinical trials, delays in development, registration and product approvals, changes in the competitive environment, increased government control over pricing, fluctuations in the capital and foreign exchange markets and the ability to maintain patent and other intellectual property protection. The information presented in this release represents management's expectations and intentions as of this date. Lupin expressly disavows any obligation to update the information presented in this release

*Keppra XR® is a registered trademark of the UCB Group of Companies.

For More Information:
Contact: Edith St-Hilaire
Director of Marketing
(410) 576-2000
esthilaire@lupinusa.com


'/>"/>
SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lupin Receives Final Approval to Market Generic Ultram® ER
2. Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
3. Lupin Launches Additional Strengths of Generic Lotrel® Capsules
4. Lupin Announces Launch of Generic Levaquin® Tablets
5. HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
6. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
7. Lupin Expands Branded Play
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at UBS Global Life Sciences Conference
9. Main Street Capital Announces New Portfolio Investment
10. Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
11. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
(Date:4/28/2016)... 28, 2016  The blood testing market in ... to Kalorama Information and The Freedonia Group in a ... acid testing.  The healthcare research firm said that ... blood collection stations and in improving testing at the ... report, Blood Testing Market in China ...
(Date:4/28/2016)... April 28, 2016 Dr. Vivek ... and Ste phen Schmidt ... a leading provider of cloud-based software solutions for life sciences, today ... to bring a wealth of insight to a growing business.  This ... George Phillips joined ArisGlobal in the position ...
Breaking Medicine Technology:
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us that ... Prevention (CDC), a stroke is the fourth leading cause of death in the United States; ... with almost a quarter of them in individuals under 65 years old. A stroke ...
(Date:4/28/2016)... ... 2016 , ... Point Source Audio® (PSA) , an ... today that the US Patent Office has approved its patent submission that covers ... design creates a lightweight and modular audio headset that has been said to ...
(Date:4/28/2016)... Cary, NC (PRWEB) , ... April 28, 2016 ... ... to announce it has partnered with Community Oncology Pharmacy Association (COPA) to develop ... elevate the practice of oncology by introducing an accreditation distinction. ACHC provides a ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... Pharmacy Discount Cards in the mail from USA Medical Prescription Assistance Program. They ... , Each mailed package will include a ready-to-use, state-themed card and, ...
(Date:4/28/2016)... ... April 28, 2016 , ... For the 10,000 Americans who turn ... an important part of overall well-being: mental health. Now, a new book—Staying Sharp For ... aging and “cognitive vitality,” which can include everything from honing your memory and managing ...
Breaking Medicine News(10 mins):